[Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice].Zhong Yao Cai. 2011 Dec; 34(12):1912-5.ZY
Abstract
OBJECTIVE
To investigate the pharmacokinetics and tissue distribution of Schisandra chinensis in mice.
METHODS
Schisandrin in mice plasma and tissues including heart, liver, spleen, lung and kidney was quantitatively determined by HPLC.
RESULTS
The concentration-time curve of Schisandra chinensis extract was described by a single compartment model, Cmax was (2.17 +/- 0.27) mg/ mL, t(max) was (1.00 +/- 0.32) h, AUC0-->infinity, was (4.07 +/- 0.62) mg x h/mL. The sequence of distribution of schisandrin in mice body was as follows: liver > plasma > kidney > lung > heart > spleen.
CONCLUSION
The distribution of extract in the body is abroad. Liver has relative high concentration of schisandrin, which is beneficial to the treatment of hepatic disease.
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
chi
PubMed ID
22500430
Citation
Guan, Jiao, et al. "[Pharmacokinetics and Tissue Distribution of Schisandra Chinensis Extract in Mice]." Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials, vol. 34, no. 12, 2011, pp. 1912-5.
Guan J, Zhu HY, Zhang XR, et al. [Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice]. Zhong Yao Cai. 2011;34(12):1912-5.
Guan, J., Zhu, H. Y., Zhang, X. R., Zhao, Y., & Sun, D. Y. (2011). [Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice]. Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials, 34(12), 1912-5.
Guan J, et al. [Pharmacokinetics and Tissue Distribution of Schisandra Chinensis Extract in Mice]. Zhong Yao Cai. 2011;34(12):1912-5. PubMed PMID: 22500430.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice].
AU - Guan,Jiao,
AU - Zhu,He-Yun,
AU - Zhang,Xiu-Rong,
AU - Zhao,Yang,
AU - Sun,De-Yi,
PY - 2012/4/17/entrez
PY - 2012/4/17/pubmed
PY - 2012/9/21/medline
SP - 1912
EP - 5
JF - Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials
JO - Zhong Yao Cai
VL - 34
IS - 12
N2 - OBJECTIVE: To investigate the pharmacokinetics and tissue distribution of Schisandra chinensis in mice. METHODS: Schisandrin in mice plasma and tissues including heart, liver, spleen, lung and kidney was quantitatively determined by HPLC. RESULTS: The concentration-time curve of Schisandra chinensis extract was described by a single compartment model, Cmax was (2.17 +/- 0.27) mg/ mL, t(max) was (1.00 +/- 0.32) h, AUC0-->infinity, was (4.07 +/- 0.62) mg x h/mL. The sequence of distribution of schisandrin in mice body was as follows: liver > plasma > kidney > lung > heart > spleen. CONCLUSION: The distribution of extract in the body is abroad. Liver has relative high concentration of schisandrin, which is beneficial to the treatment of hepatic disease.
SN - 1001-4454
UR - https://www.unboundmedicine.com/medline/citation/22500430/
DB - PRIME
DP - Unbound Medicine
ER -

